DRG 813

Medical DRG

Coagulation Disorders

TypeMedicalMDC16Dx Codes39

What is MS-DRG 813?

MS-DRG 813 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 16 (MDC 16). It maps to 39 ICD-10-CM diagnosis codes. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
Linked Codes
39 diagnosis
Billable Dx
100%
39 of 39 shown

Linked ICD-10-CM Diagnosis Mappings

  • D65

    Disseminated intravascular coagulation [defibrination syndrome]

    BillableChapter 3
  • D66

    Hereditary factor VIII deficiency

    BillableChapter 3
  • D67

    Hereditary factor IX deficiency

    BillableChapter 3
  • D68.00

    Von Willebrand disease, unspecified

    BillableChapter 3
  • D68.01

    Von Willebrand disease, type 1

    BillableChapter 3
  • D68.020

    Von Willebrand disease, type 2A

    BillableChapter 3
  • D68.021

    Von Willebrand disease, type 2B

    BillableChapter 3
  • D68.022

    Von Willebrand disease, type 2M

    BillableChapter 3
  • D68.023

    Von Willebrand disease, type 2N

    BillableChapter 3
  • D68.029

    Von Willebrand disease, type 2, unspecified

    BillableChapter 3
  • D68.03

    Von Willebrand disease, type 3

    BillableChapter 3
  • D68.04

    Acquired von Willebrand disease

    BillableChapter 3
  • D68.09

    Other von Willebrand disease

    BillableChapter 3
  • D68.1

    Hereditary factor XI deficiency

    BillableChapter 3
  • D68.2

    Hereditary deficiency of other clotting factors

    BillableChapter 3
  • D68.311

    Acquired hemophilia

    BillableChapter 3
  • D68.318

    Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

    BillableChapter 3
  • D68.32

    Hemorrhagic disorder due to extrinsic circulating anticoagulants

    BillableChapter 3
  • D68.4

    Acquired coagulation factor deficiency

    BillableChapter 3
  • D68.8

    Other specified coagulation defects

    BillableChapter 3
  • D68.9

    Coagulation defect, unspecified

    BillableChapter 3
  • D69.0

    Allergic purpura

    BillableChapter 3
  • D69.1

    Qualitative platelet defects

    BillableChapter 3
  • D69.2

    Other nonthrombocytopenic purpura

    BillableChapter 3
  • D69.3

    Immune thrombocytopenic purpura

    BillableChapter 3
  • D69.41

    Evans syndrome

    BillableChapter 3
  • D69.42

    Congenital and hereditary thrombocytopenia purpura

    BillableChapter 3
  • D69.49

    Other primary thrombocytopenia

    BillableChapter 3
  • D69.51

    Posttransfusion purpura

    BillableChapter 3
  • D69.59

    Other secondary thrombocytopenia

    BillableChapter 3
  • D69.6

    Thrombocytopenia, unspecified

    BillableChapter 3
  • D69.8

    Other specified hemorrhagic conditions

    BillableChapter 3
  • D69.9

    Hemorrhagic condition, unspecified

    BillableChapter 3
  • D75.821

    Non-immune heparin-induced thrombocytopenia

    BillableChapter 3
  • D75.822

    Immune-mediated heparin-induced thrombocytopenia

    BillableChapter 3
  • D75.828

    Other heparin-induced thrombocytopenia syndrome

    BillableChapter 3
  • D75.829

    Heparin-induced thrombocytopenia, unspecified

    BillableChapter 3
  • D75.84

    Other platelet-activating anti-PF4 disorders

    BillableChapter 3
  • R23.3

    Spontaneous ecchymoses

    BillableChapter 18